Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Do medical French students know how to properly score a mini mental state examination?

Hernandorena I, Chauvelier S, Vidal JS, Piccoli M, Coulon J, Hugonot-Diener L, Rigaud AS, Hanon O, Duron E.

Geriatr Psychol Neuropsychiatr Vieil. 2017 Jun 1;15(2):163-169. doi: 10.1684/pnv.2017.0673.

PMID:
28625936
2.

GREFON recommendations for assessment of instrumental activities of daily living in memory clinics.

Magnin E, Hugonot-Diener L, De Rotrou J, Machado C, Benisty S, Dieudonné B, Marchal D, Strub ML, Verny M; GREFON commission of the GRECO.

Rev Neurol (Paris). 2017 Apr;173(4):194-200. doi: 10.1016/j.neurol.2017.03.003. Epub 2017 Apr 6. Review.

PMID:
28392062
3.

Adapting the mini mental status to the context of the West-Indies.

Godaert L, Godard-Sebillotte C, Bousquet L, Devouche E, Hugonot-Diener L, Nuissier J, Triboulet F, Fanon JL.

Geriatr Psychol Neuropsychiatr Vieil. 2017 Mar 1;15(1):13-17. doi: 10.1684/pnv.2016.0645.

PMID:
28132937
4.

Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.

Di Stefano F, Epelbaum S, Coley N, Cantet C, Ousset PJ, Hampel H, Bakardjian H, Lista S, Vellas B, Dubois B, Andrieu S; GuidAge study group.

J Alzheimers Dis. 2015;48(3):793-804. doi: 10.3233/JAD-150013.

PMID:
26402073
5.

Guidance synthesis. Medical research for and with older people in Europe: proposed ethical guidance for good clinical practice: ethical considerations.

Diener L, Hugonot-Diener L, Alvino S, Baeyens JP, Bone MF, Chirita D, Husson JM, Maman M, Piette F, Tinker A, von Raison F; European Forum for Good Clinical Practice Geriatric Medicine Working Party.

J Nutr Health Aging. 2013 Jul;17(7):625-7. doi: 10.1007/s12603-013-0340-0.

PMID:
23933874
6.
7.

Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial.

Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S; GuidAge Study Group.

Lancet Neurol. 2012 Oct;11(10):851-9. doi: 10.1016/S1474-4422(12)70206-5. Epub 2012 Sep 6. Review.

PMID:
22959217
8.

DAD-6: A 6-ltem version of the Disability Assessment for Dementia scale which may differentiate Alzheimer's disease and mild cognitive impairment from controls.

de Rotrou J, Wu YH, Hugonot-Diener L, Thomas-Antérion C, Vidal JS, Plichart M, Rigaud AS, Hanon O.

Dement Geriatr Cogn Disord. 2012;33(2-3):210-8. doi: 10.1159/000338232. Epub 2012 May 14.

PMID:
22584691
9.

[Support for patients with Alzheimer's disease and their caregivers by gerontechnology].

Rigaud AS, Pino M, Wu YH, DE Rotrou J, Boulay M, Seux ML, Hugonot-Diener L, DE Sant'anna M, Moulin F, LE Gouverneur G, Cristancho-Lacroix V, Lenoir H.

Geriatr Psychol Neuropsychiatr Vieil. 2011 Mar;9(1):91-100. doi: 10.1684/pnv.2010.0248. Review. French.

PMID:
21586382
10.

[7/12. Organizing the therapeutic day].

Hugonot-Diener L, Feteanu D, Cohen M, Lemaire A, Bayle C, Martin ML.

Soins Gerontol. 2011 Mar-Apr;(88):43-4. French. No abstract available.

PMID:
21526546
11.

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.

Piette F, Belmin J, Vincent H, Schmidt N, Pariel S, Verny M, Marquis C, Mely J, Hugonot-Diener L, Kinet JP, Dubreuil P, Moussy A, Hermine O.

Alzheimers Res Ther. 2011 Apr 19;3(2):16. doi: 10.1186/alzrt75.

12.

EHT0202 in Alzheimer's disease: a 3-month, randomized, placebo-controlled, double-blind study.

Vellas B, Sol O, Snyder PJ, Ousset PJ, Haddad R, Maurin M, Lemarié JC, Désiré L, Pando MP; EHT0202/002 study group.

Curr Alzheimer Res. 2011 Mar;8(2):203-12.

PMID:
21222604
13.

The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study.

Sarazin M, Chauviré V, Gerardin E, Colliot O, Kinkingnéhun S, de Souza LC, Hugonot-Diener L, Garnero L, Lehéricy S, Chupin M, Dubois B.

J Alzheimers Dis. 2010;22(1):285-94. doi: 10.3233/JAD-2010-091150.

PMID:
20847406
14.

[Diogenes's syndrome: an observatory study in a Paris district].

Monfort JC, Hugonot-Diener L, Devouche E, Wong C, Péan I.

Psychol Neuropsychiatr Vieil. 2010 Jun;8(2):141-53. doi: 10.1684/pnv.2010.0215. French.

15.

[Quality of life project and care project in day care admission for Alzheimer's or similar diseases].

Martin ML, Hugonot-Diener L, Rose S.

Soins Gerontol. 2009 May-Jun;(77):28-9. French. No abstract available.

PMID:
19552178
16.

[Diagnosis and management of Alzheimer's disease and related diseases].

Haute Autorité de Santée (HAS).

Rev Neurol (Paris). 2008 Aug-Sep;164(8-9):754-74. French. No abstract available.

PMID:
19031533
17.

GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data.

Andrieu S, Ousset PJ, Coley N, Ouzid M, Mathiex-Fortunet H, Vellas B; GuidAge study GROUP.

Curr Alzheimer Res. 2008 Aug;5(4):406-15.

PMID:
18690838
18.

Development of a short form of the Severe Impairment Battery.

Saxton J, Kastango KB, Hugonot-Diener L, Boller F, Verny M, Sarles CE, Girgis RR, Devouche E, Mecocci P, Pollock BG, DeKosky ST.

Am J Geriatr Psychiatry. 2005 Nov;13(11):999-1005.

PMID:
16286444
19.

[Abridged version of the severe impairment battery (SIB)].

Hugonot-Diener L, Verny M, Devouche E, Saxton J, Mecocci P, Boller F.

Psychol Neuropsychiatr Vieil. 2003 Dec;1(4):273-83. Review. French.

20.

Clinical features and assessment of severe dementia. A review.

Boller F, Verny M, Hugonot-Diener L, Saxton J.

Eur J Neurol. 2002 Mar;9(2):125-36. Review.

PMID:
11882053

Supplemental Content

Loading ...
Support Center